title: Porcine factor VIII therapy in patients with congenital hemophilia and inhibitors: efficacy, patient selection, and side effects.
authors.affiliation: Department of Haematology, University of Liverpool, Royal Liverpool University Hospital, UK.
authors.forename: C R
authors.initials: CR
authors.lastname: Hay
authors.forename: J N
authors.initials: JN
authors.lastname: Lozier
authors.forename: C A
authors.initials: CA
authors.lastname: Lee
authors.forename: M
authors.initials: M
authors.lastname: Lafan
authors.forename: H
authors.initials: H
authors.lastname: Tradati
authors.forename: E
authors.initials: E
authors.lastname: Santagostino
authors.forename: N
authors.initials: N
authors.lastname: Ciavarella
authors.forename: M
authors.initials: M
authors.lastname: Schiavoni
authors.forename: H
authors.initials: H
authors.lastname: Fukui
authors.forename: A
authors.initials: A
authors.lastname: Yoshioka
mesh_terms: D000818:Animals; D003429:Cross Reactions; D005169:Factor VIII / Q000009:adverse effects / Q000037:antagonists & inhibitors / Q000627:therapeutic use*; D006467:Hemophilia A / Q000188:drug therapy* / Q000209:etiology / Q000276:immunology / Q000601:surgery; D006801:Humans; D007262:Infusions, Intravenous; D018579:Patient Selection; D010976:Platelet Count / Q000187:drug effects; D013552:Swine
chemical_list: D005169:Factor VIII